Delivery Order SPE2DB22D9239-SPE2DB25FDE32

Award Date 10/31/24
Potential Completion Date 11/22/24
Potential Value $27K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency Troop Support Medical has awarded a firm-fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business located in Park Ridge, Illinois. The $26,575.14 contract is for the delivery of ILARIS 150 MG/ML VIALML, with a completion date of February 29, 2024. DMS Pharmaceutical Group holds a larger indefinite-delivery contract, valued up to $4,999,999, with the Defense Logistics Agency under the SPE2DB program. This single-award...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $39,862.71 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of the medication ILARIS 150 MG/ML VIALML and has an ultimate completion date of October 9, 2024. DMS Pharmaceutical Group Inc. holds a larger indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $26,575.14, is for the delivery of ILARIS 150 MG/ML VIALML, a pharmaceutical product, to support the recurring medical supply needs of military health facilities. This delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) under...
This is a $26,575.14 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of ILARIS 150 MG/ML VIALML, a pharmaceutical product, to support the recurring medical supply needs of military health facilities. The award is not associated with a set-aside program. DMS Pharmaceutical Group holds a larger $499,999,999...
This is a firm fixed-price delivery order (SPE2DB25FX1LH) awarded by the Defense Logistics Agency (DLA), a defense agency, to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is valued at $26,575.14 and covers the delivery of ILARIS 150 MG/ML vial, a specialized pharmaceutical product, with a completion date of November 26, 2024. DMS Pharmaceutical Group Inc. holds a larger Indefinite Delivery Contract (IDC) with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $26,575.14 firm fixed-price delivery order is for the provision of Ilaris 150 mg/mL vial, a specialized pharmaceutical product. The contract is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. This IDC enables...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $76,965.06, is for the delivery of ILARIS 150 MG/ML VIALML, a specialized pharmaceutical product. The contract has an ultimate completion date of February 4, 2025 and is not associated with any set-aside designation. DMS Pharmaceutical Group Inc. holds a...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $12,827.51 contract is for the delivery of ILARIS 150 MG/ML vials, with a performance period ending on April 3, 2025. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to issue delivery...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $26,575.14 contract is for the delivery of ILARIS 150 MG/ML VIALML, a pharmaceutical product, with a completion date of June 25, 2024. The contract is not associated with a set-aside program. DMS Pharmaceutical Group holds a $499,999,999 indefinite delivery contract (IDC) with the DLA...
This is a federal contract award to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business based in Park Ridge, Illinois. The contract, awarded by the Defense Logistics Agency (DLA), is a delivery order valued at $159,450.84 with a period of performance through April 1, 2024. The contract is a firm fixed-price vehicle that does not have a set-aside designation. The contract provides for the delivery of a pharmaceutical product, ILARIS 150 MG/ML VIALML, to support the medical...
  • SPE2DB22D9239
    Indefinite Delivery Contract
  • SPE2DB22D9239-SPE2DB25FDE32
    Delivery Order

The Defense Logistics Agency (DLA) has awarded a $26,575.14 firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of ILARIS 150 MG/ML VIALML, a specialized pharmaceutical product. This delivery order is part of a larger $499,999,999 indefinite delivery contract awarded to DMS Pharmaceutical Group by DLA under the SPE2DB program, which provides a comprehensive range of branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables to support the medical supply needs of military health facilities worldwide. The contract has an ultimate completion date of November 22, 2024 and does not have a set-aside designation.

Generated 1/30/25, 9:03 AM